Deal type reports

Essential Benchmark Data for Dealmakers - The Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2022 report is your one-stop source for providing real-deal information on hundreds of transactions, including the technology licensed, royalty rates, license fees, upfront and milestone payments.

The Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022 report provides comprehensive understanding and unprecedented access to the joint venture partnering agreements entered into by the worlds leading healthcare companies.

The Global Co-development Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2015-2022 report provides comprehensive understanding and unprecedented access to the co-development deals and agreements entered into by the worlds leading healthcare companies.

The Global Collaborative R&D Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2016-2022 report provides comprehensive understanding and unprecedented access to the collaborative R&D partnering deals and agreements entered into by the worlds leading healthcare companies.

The Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2016-2022 report provides comprehensive understanding and unprecedented access to the licensing deals and agreements entered into by the worlds leading life science companies

The All In One Partnering Intelligence Platform

Get unlimited access to our collection of partnering reports, conveniently and easily, while maximizing your time and budget

Powerful Intelligence for Dealmakers...

Leading deals and alliances database for the life sciences sector

The Global Option and Evaluation Deals in Pharma, Biotech and Diagnostics 2015-2022 report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies.

The Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2015-2022 report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty asset purchase deals.

The Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015 - 2022 report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements entered into by the world’s biopharma companies